DNA Damage in Stem Cells

Slides:



Advertisements
Similar presentations
Repairing Damages Bases 1. Mismatch repair (MMR) Dam methylase:MutS:
Advertisements

Cellular Responses to DNA Damage Kate Dixon Department of Molecular and Cellular Biology
DNA Repair and Cancer. Genome Instability Science, 26 July 2002, p. 544.
Chapter 16 Repair Systems Introduction mismatch repair (MMR) – A type of repair that corrects mispaired bases, typically immediately following replication.
ReactionBasePairingMutationMispairing DeaminationCGUA ATHypoxanthineC DeaminationGCXanthineC AkylationCG5’-methyl C Gene scilencing or A AkylationGCO6-methyl.
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Targeting the DNA Damage Response in Cancer
Volume 15, Issue 1, Pages (July 2014)
DNA damage DNA gets damaged a lot! >200,000 events/human cell/day.
Repair of mtDNA in Vertebrates
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Xuan Li, Carrie M. Stith, Peter M. Burgers, Wolf-Dietrich Heyer 
Shelterin Current Biology
Felix Dietlein, Lisa Thelen, H. Christian Reinhardt  Trends in Genetics 
Errol C. Friedberg, Alan R. Lehmann, Robert P.P. Fuchs  Molecular Cell 
The DNA Damage Response: Ten Years After
Volume 49, Issue 2, Pages (January 2013)
CHIPping Away at Base Excision Repair
Figure 1 Putative anticancer mechanisms of action of PARP inhibitors
Targeting HSP70 for Cancer Therapy
Volume 20, Issue 5, Pages (December 2005)
Saving the Ends for Last: The Role of Pol μ in DNA End Joining
Origin of Chromosomal Translocations in Lymphoid Cancer
Cellular Senescence in Cancer and Aging
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
DNA Polymerases at the Replication Fork in Eukaryotes
Yea-Lih Lin, Philippe Pasero  Molecular Cell 
Fungal BRCA2 Ortholog Brh2 Brings 5′ End Strand Invasion Back on Stage
Volume 137, Issue 2, Pages (May 2015)
RNA Processing and Genome Stability: Cause and Consequence
Recombination Mechanisms
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Not So Lonely at the Top for Cancer Stem Cells
Regulation of DNA Damage Responses by Ubiquitin and SUMO
Eukaryotic Transcription Activation: Right on Target
Volume 153, Issue 6, Pages (June 2013)
DNA Mismatch Repair: Dr. Jekyll and Mr. Hyde?
Graeme Hewitt, Viktor I. Korolchuk  Trends in Cell Biology 
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Lucas T. Gray, Alan M. Weiner  Molecular Cell 
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Do DNA Double-Strand Breaks Drive Aging?
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
DNA Double-Strand Breaks Come into Focus
Proteins Kinases: Chromatin-Associated Enzymes?
DNA DSB repair signaling pathways through the apical DDR kinases.
Fanconi Anemia (Cross)linked to DNA Repair
Andrew N. Blackford, Stephen P. Jackson  Molecular Cell 
Avanti Kulkarni, David M. Wilson 
Endogenous DNA Damage as a Source of Genomic Instability in Cancer
The DNA Damage Response: Making It Safe to Play with Knives
Graeme Hewitt, Viktor I. Korolchuk  Trends in Cell Biology 
Molecular Mechanisms of Long Noncoding RNAs
Complicated Tails: Histone Modifications and the DNA Damage Response
Epigenome Maintenance in Response to DNA Damage
Nancy E. Thomas, Marianne Berwick, Marila Cordeiro-Stone 
SAMHD1 Sheds Moonlight on DNA Double-Strand Break Repair
At Loose Ends: Resecting a Double-Strand Break
Are Mouse Telomeres Going to Pot?
The DNA Damage Response: Ten Years After
Volume 61, Issue 2, Pages (January 2016)
Michael J. McIlwraith, Stephen C. West  Molecular Cell 
The DNA Damage Response: Making It Safe to Play with Knives
TGF-β Pathway Inhibition Signals New Hope for Fanconi Anemia
Effects of PARP inhibition on the DNA damage response.
FANCD2 Hurdles the DNA Interstrand Crosslink
Overcoming ATM Deficiency by Activating the NAD+/SIRT1 Axis
Presentation transcript:

DNA Damage in Stem Cells Ilio Vitale, Gwenola Manic, Ruggero De Maria, Guido Kroemer, Lorenzo Galluzzi  Molecular Cell  Volume 66, Issue 3, Pages 306-319 (May 2017) DOI: 10.1016/j.molcel.2017.04.006 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Main Molecular Pathways Underlying DNA Repair and the DDR (A) Genetic defects as different as abasic sites (a), mildly distorting lesions (b), SSBs (c), deaminations (d), T-T dimers (e), distorting lesions (f), insertion/deletion loops (IDLs) (g), base-base mispairs (h), DSBs (i), end-resected DSBs (j), and ssDNA stretches adjacent to dsDNA (k) can be efficiently repaired by specialized mechanisms encompassing base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), non-homologous end joining (NHEJ), and homologous recombination (HR). Alternatively, multiple DNA lesions can be tolerated upon translesion synthesis (TLS). Please refer to the main text for the official and common names of the proteins and multiprotein complexes involved in these pathways. (B) In response to ssDNA stretches adjacent to dsDNA or DSBs, ATR and ATM, respectively, activate signal transduction pathways that are involved in the maintenance of nuclear, cellular, or organismal homeostasis, including regulated cell death (RCD). EPE, end-processing enzyme; Gly, glycosydase; MRN, MRE11-RAD50-NBS1; POLδ, polymerase δ; POLζ, polymerase ζ; Y-POL, Y-family polymerase. Molecular Cell 2017 66, 306-319DOI: (10.1016/j.molcel.2017.04.006) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Targeting DNA Repair in Cancer Stem Cells In physiological conditions, chemo- and radioresistant CSCs self-renew as they generate relatively more chemo- and radiosensitive malignant cells with limited stemness. Multiple components of the DDR can be directly or indirectly targeted as a standalone strategy for the preferential eradication of CSCs or as a means to boost their chemo- and radiosensitivity, via differentiation, regulated cell death (RCD), or cellular senescence. Molecular Cell 2017 66, 306-319DOI: (10.1016/j.molcel.2017.04.006) Copyright © 2017 Elsevier Inc. Terms and Conditions